Benefits of Usability Evaluation in the Development Process of Diabetes Technologies Using the Example of a Continuous Glucose Monitoring System Prototype

被引:0
|
作者
Beltzer, Anne [1 ]
Koelle, Julia [1 ]
Miro, Marta Gil [1 ]
Pleus, Stefan [1 ]
Krauss, Collin [1 ]
Haug, Cornelia [1 ]
Safary, Elvis [2 ]
Vetter, Beatrice [2 ]
Freckmann, Guido [1 ]
机构
[1] Univ Ulm, Inst Diabet Technol Forsch & Entwicklungsgesell mb, Lise Meitner Str 8-2, D-89081 Ulm, Germany
[2] FIND, Geneva, Switzerland
关键词
continuous glucose monitoring; diabetes technology; human factors; SUS score; usability; use error; INSULIN INJECTIONS; ADULTS; TYPE-1;
D O I
10.1177/19322968241238146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Usability engineering analyzes the interaction between the intended users and a device. Its implementation is mandatory for manufacturers to obtain regulatory approval for the European market. The aim of this evaluation was assessing the role of usability testing in the development process. For this purpose, a continuous glucose monitoring (CGM) device under development was investigated to determine whether it could be used safely and effectively by the intended users.Methods: Conduct of the usability testing was based on the international standard IEC 62366-1. Medical device use of CGM-experienced and non-experienced users (n = 15 each) was observed without initial training in use scenarios containing 18 tasks. The success rate of task completion was determined and the System Usability Scale (SUS) score was calculated from a questionnaire. A prototype of the FiberSense CGM System (EyeSense GmbH, Gro ss ostheim, Germany), comprising of a single-use sensor and a reusable detector, was investigated.Results: Most use errors made by both user groups were related to ease of handling of the reusable detectors. The SUS scores achieved in this study were below the pre-defined SUS score acceptance criterion of >= 68. The most frequently mentioned reason for use errors was an incomprehensible and non-chronological instructions for use (IFU).Conclusions: The evaluation provides valuable insights on how to improve usability of the prototype device and demonstrates the value of conducting structured usability testing prior to product finalization. The results reflected areas for improvement of the user interface, mainly by restructuring the IFU, provision of an additional leaflet, and device training prior to use.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Italian Contributions to the Development of Continuous Glucose Monitoring Sensors for Diabetes Management
    Sparacino, Giovanni
    Zanon, Mattia
    Facchinetti, Andrea
    Zecchin, Chiara
    Maran, Alberto
    Cobelli, Claudio
    SENSORS, 2012, 12 (10) : 13753 - 13780
  • [42] Assessing Glycemic Control in Diabetes: From Self Monitoring of Blood Glucose to Continuous Glucose Monitoring System
    Gribovschi, M.
    Fodor, A.
    Grosu, G.
    Hancu, N.
    INTERNATIONAL CONFERENCE ON ADVANCEMENTS OF MEDICINE AND HEALTH CARE THROUGH TECHNOLOGY, 2009, 26 : 29 - +
  • [43] PROJECTION OF HEALTH ECONOMICS BENEFITS OF CONTINUOUS GLUCOSE MONITORING VERSUS SELF MONITORING OF BLOOD GLUCOSE IN TYPE 1 DIABETES, IN SWEDEN
    Roze, S.
    Valentine, W. J.
    Hanas, R.
    Barsoe, C.
    VALUE IN HEALTH, 2012, 15 (04) : A69 - A69
  • [44] HEALTH ECONOMIC BENEFITS OF CONTINUOUS GLUCOSE MONITORING (CGM) VERSUS SELF MONITORING OF BLOOD GLUCOSE (SMBG) IN TYPE 1 DIABETES
    Roze, S.
    Lynch, P.
    Brandt, A. S.
    Barsoe, C.
    Jendle, J.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A65 - A65
  • [45] Enhanced Algorithm for glucose estimation using the Continuous Glucose Monitoring System
    Leal, Yenny
    Garcia-Gabin, Winston
    Bondia, Jorge
    Esteve, Eduardo
    Ricart, Wifredo
    Fernandez-Real, Jose-Manuel
    Vehi, Josep
    MEDICAL SCIENCE MONITOR, 2010, 16 (06): : MT51 - MT58
  • [46] Evaluation of a Novel Continuous Glucose Monitoring System in Insulin-Treated Patients with Diabetes: A Pilot Study
    Tomah, Shaheen
    Eldib, Ahmed H.
    Tasabehji, Mhd Wael
    Bhatia, Vikas
    Gardner, Hannah
    Hamdy, Osama
    DIABETES, 2020, 69
  • [47] Safety and performance evaluation of a novel continuous glucose monitoring system: Lumee Glucose
    Nguyen, C.
    Tran, N. Q.
    Ma, P. T.
    Nguyen, H. T.
    Gamsey, S.
    Lepak, C.
    Cereceres, S.
    Rebrin, K.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 285 - 285
  • [48] Performance of a new continuous glucose monitoring (CGM) system in youth with diabetes
    Laffel, L.
    Chase, P.
    Bailey, T.
    Buckingham, B.
    Liljenquist, D.
    Daniels, M.
    Nakamura, K.
    DIABETOLOGIA, 2013, 56 : S440 - S440
  • [49] Accuracy of real-time glucose values using continuous glucose monitoring:: the Guardian™ II continuous glucose monitoring system
    Schwartz, SL
    Buchea, O
    Shin, J
    Hoss, U
    Shah, R
    DIABETOLOGIA, 2004, 47 : A315 - A315
  • [50] The Effect of the Menstrual Cycle on Glucose Control in Women With Type 1 Diabetes Evaluated Using a Continuous Glucose Monitoring System
    Barata, Denise S.
    Adan, Luis F.
    Netto, Eduardo M.
    Ramalho, Ana Claudia
    DIABETES CARE, 2013, 36 (05) : E70 - E70